Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Other Accumulated Expenses (2016 - 2024)

Historic Other Accumulated Expenses for Firefly Neuroscience (AIFF) over the last 10 years, with Q2 2024 value amounting to $230024.0.

  • Firefly Neuroscience's Other Accumulated Expenses fell 5507.45% to $230024.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $230024.0, marking a year-over-year decrease of 5507.45%. This contributed to the annual value of $267604.0 for FY2023, which is 560.61% down from last year.
  • According to the latest figures from Q2 2024, Firefly Neuroscience's Other Accumulated Expenses is $230024.0, which was down 5507.45% from $168658.0 recorded in Q1 2024.
  • In the past 5 years, Firefly Neuroscience's Other Accumulated Expenses ranged from a high of $816536.0 in Q1 2022 and a low of $7656.0 during Q2 2020
  • Moreover, its 5-year median value for Other Accumulated Expenses was $223566.0 (2023), whereas its average is $274381.1.
  • In the last 5 years, Firefly Neuroscience's Other Accumulated Expenses crashed by 8630.22% in 2020 and then skyrocketed by 1004708.59% in 2022.
  • Over the past 5 years, Firefly Neuroscience's Other Accumulated Expenses (Quarter) stood at $54274.0 in 2020, then skyrocketed by 276.02% to $204080.0 in 2021, then soared by 38.91% to $283497.0 in 2022, then fell by 5.61% to $267604.0 in 2023, then dropped by 14.04% to $230024.0 in 2024.
  • Its Other Accumulated Expenses was $230024.0 in Q2 2024, compared to $168658.0 in Q1 2024 and $267604.0 in Q4 2023.